Arizona Tribune - Boulevard

NYSE - LSE

RYCEF	3.4%	18.8	$
CMSC	0.29%	22.13	$
NGG	0.34%	83.11	$
GSK	1.89%	52.075	$
RIO	1.26%	95.23	$
CMSD	-0.78%	21.85	$
BCE	-0.72%	23.035	$
RBGPF	0%	61.3	$
BCC	1.28%	78.67	$
VOD	0.14%	13.83	$
BTI	0.9%	61.945	$
AZN	1%	184.87	$
JRI	0.24%	12.6	$
RELX	0.34%	31.255	$
BP	0.2%	37.935	$

Featured

HRW denounces Turkey arrests ahead of NATO summit

Human Rights Watch on Thursday denounced Turkey's arrest of over 200 people ahead of the NATO summit in Ankara, saying it showed a "ruthless intolerance" of freedom of speech and assembly.

Venezuelans trapped alive after twin quakes kill at least 164

Desperate Venezuelans battled Thursday to rescue loved ones trapped alive beneath the rubble of collapsed buildings after two major earthquakes that killed at least 164 people.

Last news

What's a cardinal? The 'princes' of the Church electing a new pope

Cardinals from all over the world will gather in conclave on Wednesday to elect a successor to Pope Francis. But what exactly is a cardinal?

Papal conclave by the numbers

The Vatican's papal conclave to choose a new spiritual leader for the world's 1.4 billion Catholics is governed by procedures and rituals that have evolved over centuries.

The Vatican: a papal powerhouse, world's smallest state

The Vatican, headquarters of the Catholic Church, is the smallest state in the world, with its own newspaper, national anthem in Latin and supreme leader: the pope.

History beckons as cardinals gather to elect new pope

Cardinals from across the world will be shut into the Sistine Chapel on Wednesday for a secretive conclave to elect the next head of the world's 1.4 billion Catholics.

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

DENVER, CO / ACCESS Newswire / May 7, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its third quarter of fiscal 2025, after the market close on Wednesday, May 14, 2025. The Company has scheduled a conference call and webcast that same day, Wednesday, May 14, 2025, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.

Envela Reports First Quarter 2025 Financial Results

IRVING, TX / ACCESS Newswire / May 7, 2025 / Envela Corporation today announced its financial results for its first quarter ended March 31, 2025. The Company reported quarterly revenue of $48.3 million and quarterly earnings per diluted share of $0.10.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Reports Net Revenues of $170.5 Million for the Three Months Ended March 31, 2025

The Barber Shop Marketing Wins National Recognition for Creative Excellence and Strategic Campaigns

Leading North Texas Advertising Agency Represented City of Richardson and Town of Addison

AcutePet Urgent Care Opens in Summerville, SC - Bringing Affordable Emergency-Level Care to Local Pet Owners

New location offers extended hours and same-day urgent care for pets-seven days a week.

Organic Produce Summit Announces Dynamic Industry Education Sessions

MONTEREY, CA / ACCESS Newswire / May 7, 2025 / Organic Produce Summit today unveils premier lineup of keynote sessions and educational panels that will bring together industry leaders to explore the latest trends and innovations in organic produce. The event will take place July 9-10, 2025, in Monterey, CA.

Inside Self-Storage World Expo Delivers Comprehensive Industry Insights and New Show Features

LAS VEGAS, NV / ACCESS Newswire / May 7, 2025 / Inside Self-Storage (ISS) World Expo, the self-storage industry's largest annual conference and tradeshow, engaged the community with four days of conference programming and two days of exhibits, April 22-25, driving advancement in facility development, investment, operation and much more.

Aster Guardians Global Nursing Award Unveils Top 10 Finalists for 2025 from 100,000+ Registrations

Over 100,000 registrations received from nurses across 199* countries - a 28% increase from the third edition, which received 78,000+ registrations.One of the shortlisted Top 10 finalists will be honoured with the grand title award and a prize of USD 250,000.These finalists were selected following a rigorous evaluation process, led by esteemed expert jury and grand jury panels. The entire process is independently moderated by the appointed "Process Advisors" Ernst & Young LLP.

Announcing the Inaugural Recipient of the Steve Fairfield Memorial Award for Flexible Packaging Innovation

Steve Gosling of Cheer Pack North America Named First Recipient of Annual Award

Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab

Ludwig Enterprises, Inc. (OTC:LUDG), previews its first in a pipeline of non-invasive cancer screening tests powered by mRNA biomarker analysis.

Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts

Crofelemer is the only oral drug approved by the FDA's Center for Drug Evaluation and Research under Botanical GuidanceClick here to access replay of company's April 30, 2025 investor webcast

Dolphin Clients Shine at the 2025 Met Gala

MIAMI, FL / ACCESS Newswire / May 7, 2025 / Once again, Dolphin (NASDAQ:DLPN) clients and partners were front and center at one of the year's most iconic cultural moments. From the Academy Awards to the Grammys, Fashion Week to the Super Bowl, and across major music and food festivals, Dolphin's influence is felt wherever pop culture is made - including the 2025 Met Gala.

DirectTrust(R) Announces Appointment of Two New Board Members

Ryan Howells and Ryan Smith bring extensive expertise in digital health innovation and interoperability

Telomir Pharmaceuticals Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia

MIAMI, FLORIDA / ACCESS Newswire / May 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), a leader in age-reversal science, today announced new preclinical data showing that its lead oral drug candidate, Telomir-1, reverses multiple hallmarks of cellular decline across several human cell lines. The findings include improved mitochondrial activity, reduced oxidative stress, restored calcium balance, and protection from toxic metal effects-offering a mechanistic foundation for the Company's new research initiatives in autism spectrum disorder (ASD) and spasmodic dysphonia (SD).

TRIANA Biomedicines Announces the Appointment of Caroline Germa as Chief Medical Officer and Attracts Leading Drug Discovery and Development Expert to its Scientific Advisory Board

CMO appointment strengthens the leadership team in preparation for advancement of the first product into the clinicDr. Robert Abraham appointed as Scientific Advisory Board Chair

ConEquip Kicks Off Season 5 of "America's Hardest Worker" with $6,000 in Cash Prizes and a Honda Side-by-Side Grand Prize

Recognizing dedication across America's workforce with meaningful prizes and powerful stories

CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement

BEIJING, CHINA / ACCESS Newswire / May 7, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") dated May 5, 2025 stating that the Company is not in compliance with the requirement to maintain a minimum Market Value of Listed Securities ("MVLS") of $35 million as set forth under Nasdaq Listing Rule for continued listing on The Nasdaq Capital Market.

Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on Sportstech's Strong April 2025 and LTM Performance

Sportstech Announced Strong Results, with April 2025 revenue growth at 36% YOYCurrent FX rates indicate that the LTM figures would be approximately $54M in Revenue and $5M in EBITDA through April 2025Strong Business Momentum, Revenue and Positive EBITDA Underscore Target's Operational Strength and Logic of Acquisition in advance of Closing

Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies.

Motown legend Smokey Robinson sued for sexual assault

Motown legend Smokey Robinson was facing a multimillion dollar lawsuit on Tuesday from four former housekeepers who allege the soul singer repeatedly raped and sexually assaulted them.

Israel's plan for Gaza draws international criticism

Israel drew international condemnation on Tuesday over its plans for an expanded Gaza offensive, as the country's far-right finance minister called for the Palestinian territory to be "destroyed".

Top US court allows Trump's ban on trans troops to take effect

A divided US Supreme Court on Tuesday allowed President Donald Trump's ban on transgender military personnel to take effect while litigation proceeds, putting thousands of troops at risk of dismissal.

Sudan cuts ties with UAE, accused of backing paramilitaries

Sudan's army-aligned government on Tuesday severed diplomatic ties with the United Arab Emirates, accusing the Gulf state of supplying weapons used by the rival paramilitaries to strike its de facto capital.

'Wagatha Christie': Vardy and Rooney settle on legal costs

The years-long libel battle between England footballer wife Rebekah Vardy and Coleen Rooney drew to a close on Tuesday with a specialist UK court ordering Vardy to pay some £1.4 million to her rival.

Move over Met Ball. For fashion wow head to the Vatican

Forget feathers, fringe and sparkles. But if bold and brash colour is your thing, look no further than the conclave at the Vatican.

Cardinals to move into Vatican on eve of conclave

Cardinals will on Tuesday begin moving into the Vatican accommodation where they will stay during the conclave, on the eve of their historic, secretive meeting to elect a new pope.

How a privately owned city in Kenya took on corrupt officials

To many, Tatu City on the outskirts of Nairobi looks like a success.

Australian mushroom murder suspect rejected help preparing meal: witness

An Australian woman accused of murdering three people with a toxic mushroom-laced lunch rejected offers of help before serving the dish, the sole guest to survive the deadly meal told a court on Tuesday.

Arizona Tribune - Boulevard (English)